TCL Archive Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease By Cancer History Project January 25, 2013
TCL Archive Ibrutinib Produces 68% Overall Response Rate in Phase II Trial By Cancer History Project January 25, 2013
TCL Archive Researchers Uncover Tumors Sensitive to Chemotherapy By Cancer History Project January 25, 2013
TCL Archive Researchers Find Genetic Alterations in Triple-Negative Cancers Following Treatment By Cancer History Project January 25, 2013
TCL Archive Existing HER2 Drugs May Help More In Breast Cancer Treatment By Cancer History Project January 25, 2013
TCL Archive Smoking Intensity and Markers Predict Cancer Aggressiveness By Cancer History Project January 25, 2013
TCL Archive Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk By Cancer History Project January 25, 2013
TCL Archive No Difference in Toxicity Between IMRT and PRT In Medicare Patients By Cancer History Project January 25, 2013
Primary SourceSpotlight Article Marsha Henderson: “You have to continue to push for what you think is the right thing for public health.” By Cancer History Project
PeopleSpotlight Article Felix Feng: The Feng Symposium on Prostate Cancer Revolutions Special Lecture By Cancer History Project
